The forecasted share of corresponding/leading authorship in scientific publications within the Immunology and Microbiology fields in the US shows a steady incremental trend from 2024 to 2028, growing from 94.27% to 94.88%. This equates to a compound annual growth rate (CAGR) of approximately 0.3% over the five-year period. This upward trajectory underscores a sustained emphasis on collaborations driven by leading authors.

Future trends to observe in this context include:

Potential shifts in authorship dynamics due to increasing collaborations and multi-institutional projects.
The influence of emerging technologies and methodologies on authorship distribution.
Impact of new scientific policies on author contributions and recognition.